(Q44442885)

3 December 2017

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. (English)

1 reference

3 December 2017

1 reference

3

1 reference

3 December 2017

4

1 reference

3 December 2017

Monika van Zonneveld

1

1 reference

3 December 2017

Pieter Honkoop

2

1 reference

3 December 2017

Sarwa Darwish Murad

5

1 reference

3 December 2017

Robert A de Man

6

1 reference

3 December 2017

Solko W Schalm

7

1 reference

3 December 2017

Harry L A Janssen

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

3 December 2017

1 reference

3 December 2017

39

1 reference

3 December 2017

3

1 reference

3 December 2017

804-810

1 reference

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

3 December 2017

1 reference

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

Hepatitis B virus infection

21 January 2018

1 reference

7 January 2021

The long-term course of chronic hepatitis B.

1 reference

7 January 2021

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

1 reference

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

7 January 2021

Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial

1 reference

7 January 2021

Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B

1 reference

7 January 2021

Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.

1 reference

7 January 2021

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

1 reference

7 January 2021

Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study.

1 reference

7 January 2021

Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial

1 reference

7 January 2021

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

7 January 2021

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.

1 reference

7 January 2021

Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays

1 reference

7 January 2021

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

7 January 2021

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group

1 reference

7 January 2021

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

7 January 2021

The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B. The Long-Term Follow-up Investigator Group. The European Study Group on Viral Hepatitis (EUROHEP). Executive Team on Anti-Viral Treatment.

1 reference

7 January 2021

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

7 January 2021

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications

1 reference

7 January 2021

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

7 January 2021

Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20128

1 reference

3 December 2017

1 reference